Results 1 to 10 of about 12,603 (200)
Efficacy of Different Combination Therapies for Mania in Bipolar Disorder: A Systematic Review and Meta‐Analysis [PDF]
Brain and BehaviorObjective To systematically evaluate the efficacy and safety of different combination therapies in the treatment of mania in bipolar disorder, and to provide evidence‐based support for individualized clinical treatment.
Peiling Yao, Pingan Ni, Liqin Yin
doaj +3 more sources
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness [PDF]
New England Journal of Medicine, 2018 BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute ...
Timothy D Girard +2 more
exaly +3 more sources
Comparison of ziprasidone and olanzapine on cognitive function in patients with schizophrenia at different stages: a prospective study in Huai’an, China [PDF]
Frontiers in Behavioral NeuroscienceObjectiveTo compare the effects of ziprasidone and olanzapine on cognitive function in patients with first-episode schizophrenia and chronic schizophrenia at different stages.MethodsCognitive function tests were performed on chronic schizophrenic ...
Jingjing Yao +7 more
doaj +2 more sources
Impact of CYP3A4 functional variability on ziprasidone metabolism [PDF]
Frontiers in PharmacologyIntroductionZiprasidone is primarily metabolized by CYP3A4, an enzyme with genetic variability and susceptibility to inhibition or induction. This study explored the functional variability of CYP3A4 in ziprasidone metabolism, focusing on drug ...
Qi Zhou +8 more
doaj +2 more sources
Reclaiming Pharmacovigilance: Bridging the Evidence-Practice Gap in Psychopharmacology. [PDF]
J Eval Clin PractJournal of Evaluation in Clinical Practice, Volume 32, Issue 2, March 2026.
De Las Cuevas C.
europepmc +2 more sources
Pharmacy, 2023 This systematic review compared the efficacy and tolerance of oral antipsychotics (APDs) used in the treatment of schizophrenia following the PRISMA-P© statement (n = 21).
Zina Sherzad Qadir +2 more
doaj +1 more source
Biomedicines, 2022 Background: Atypical antipsychotics increase the risk of atrial arrhythmias and sudden cardiac death. This study investigated whether ziprasidone, a second-generation antipsychotic, affected intracellular Ca2+ and Na+ regulation and oxidative stress ...
Buh-Yuan Tai +4 more
doaj +1 more source
European Psychiatry, 2022 Introduction Ziprasidone is an atypical antipsychotic that has demonstrated efficacy for the treatment of bipolar disorder and schizophrenia. There is some preliminary evidence for Ziprasidone use in children and adolescents with several open label ...
A. Wadhwa +3 more
doaj +1 more source
European Psychiatry, 2022 Introduction Studies have demonstrated that Ziprasidone use may be beneficial in children. Determining its potential risks and benefits when used in children is therefore important.
J. Jay +7 more
doaj +1 more source